Common · Knowledge
YCT529
Chemical compound
YCT529 is an experimental non-hormonal male contraceptive developed by YourChoice Therapeutics. It functions as a selective antagonist of the retinoic acid receptor alpha (RAR-α), a nuclear receptor involved in vitamin A signaling. By inhibiting RAR-α, YCT529 disrupts spermatogenesis, leading to temporary infertility.
1 copy in circulation
From Wikipedia
YCT529 is an experimental non-hormonal male contraceptive developed by YourChoice Therapeutics. It functions as a selective antagonist of the retinoic acid receptor alpha (RAR-α), a nuclear receptor involved in vitamin A signaling. By inhibiting RAR-α, YCT529 disrupts spermatogenesis, leading to temporary infertility. YCT529 targets RAR-α, which plays a crucial role in the vitamin A signaling pathway essential for sperm production. By selectively inhibiting RAR-α, the drug impedes the development and maturation of sperm cells without affecting other physiological processes governed by vitamin A.
Text: Wikipédia, CC BY-SA 4.0. · Image: User:Innerstream (Public domain) ·
Related cards
-
★
YK-11
Chemical compound
-
★
Nonoxynol-9
Chemical compound
-
★
5α-Reductase inhibitor
Class of medications with antiandrogenic effects used primarily in the treatment of enlarged prostate and scalp hair loss
-
★
Serotonin antagonist and reuptake inhibitor
Class of drugs
-
★★★
Dapoxetine
Chemical compound
-
★★
5α-Reductase
Enzyme family